Skin ConditionNCT05101421
Rice Ceramide Supplementation and Skin Health
A study testing Rice ceramide supplementation in people with Skin Condition, run by Nexus Wise Sdn Bhd at 2 sites in Malaysia.
Trial summary
Ceramides have been added to newer cosmetic products to improve skin barrier function and exogenously replenish skin ceramides. Of the stratum corneum intercellular lipids, Ceramides are the most effective at restoring barrier function and increasing skin hydration. Read more about this study
- Who is it for?
- Ages 20 to 45 yearsHealthy volunteers can take part
- Conditions the study is for
- Skin Condition
- What is being tested?
- Rice ceramide supplementation
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 2 sitesMalaysia
- Study dates
- 1 Sep 2021to 31 Mar 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 45 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Good general health
- Free from any skin diseases
- Willing to comply with rice ceramide consumption plan
- Willing to give consent
Who cannot join
- Undergoing medication plan for skin condition
- Undergone major surgical procedures in the past six months
- Pregnant or lactating woman
Trial locations and contacts
2 sites in 1 country.
Malaysia2 sites
UCSI University
Cheras, Kuala Lumpur, 56000
Nexus Wise Sdn. Bhd.
Petaling Jaya, Selangor, 47400
About this study
Official title: The Effects of Rice Ceramide Supplementation in Improving Skin Health
Ceramides have been added to newer cosmetic products to improve skin barrier function and exogenously replenish skin ceramides. Of the stratum corneum intercellular lipids, Ceramides are the most effective at restoring barrier function and increasing skin hydration. Different ceramides have been incorporated into cosmetic formulations, but understanding the differences between ceramides used in formulations, or even identifying ceramides in formulations can be complex. This is mostly because of an archaic nomenclature system that is fundamentally flawed based on current scientific evidence. In the recent past, due to the unique bioactive components of rice, it has been explored to a certain limit for its components. Further, much attention has been paid to the plant ceramide with its incorporation into cosmetics and food preparations owing to its safety in contrast to animal/synthetic origin. There are reports on plant ceramide deciphering its protective effects on human skin by preventing moisture loss. It has been anticipated that ceramides, fatty acids, and cholesterol in combination with hydrocortisone (HC) can be an useful therapeutic agents against xerosis and atopic dermatitis.
The beneficial effects of oral intake of plant-derived ceramides for skin hydration and skin barrier reinforcement have been established in several studies involving animal models as well as human subjects. Ingestion of konjac ceramides has also shown positive effects in atopic dermatitis patients as well as healthy volunteers. Results showed improved skin symptoms and reduced skin allergic responses. The foregoing studies support the beneficial effects of oral intake of plant ceramides and their potential complementary and alternative therapeutic applications in the restoration and maintenance of skin barrier function. However, the findings from human study are still very limited, more detailed and comprehensive studies are still required to document the clinical efficacy of oral supplementation of ceramides. Thus, this study aims to evaluate the effects of rice ceramides consumption in improving skin health.
Read the detailed description
EFFECTS OF RICE CERAMIDES IN IMPROVING SKIN HEALTH - STUDY PROTOCOL
INTRODUCTION
Background
Ceramides are important structural components of the epidermis, which plays a key role in maintaining homeostasis of the human body. Specifically, its outermost layer, known as the stratum corneum, forms a barrier between the external environment and the internal body. This barrier function serves multiple purposes including prevention of water loss and protection from foreign insult. The structure of the stratum corneum is often referred to as ''brick and mortar''. The ''bricks'' are terminally differentiated keratinocytes composed mostly of keratin filaments and filaggrin. The ''mortar'' is composed of intercellular lipids arranged into lamellar layers consisting of ceramides, free fatty acids, and cholesterol. Ceramides are the predominant lipid comprising approximately 50% of the intercellular lipid content by mass. Stratum corneum lipids are essential for maintaining skin barrier function and preventing transepidermal water loss (TEWL). Disruptions or damage to the stratum corneum can impair skin barrier function and result in TEWL.
Ceramides have been added to newer cosmetic products to improve skin barrier function and exogenously replenish skin ceramides. Of the stratum corneum intercellular lipids, Ceramides are the most effective at restoring barrier function and increasing skin hydration. Different ceramides have been incorporated into cosmetic formulations, but understanding the differences between ceramides used in formulations, or even identifying ceramides in formulations can be complex. This is mostly because of an archaic nomenclature system that is fundamentally flawed based on current scientific evidence. In the recent past, due to the unique bioactive components of rice, it has been explored to a certain limit for its components. Further, much attention has been paid to the plant ceramide with its incorporation into cosmetics and food preparations owing to its safety in contrast to animal/synthetic origin. There are reports on plant ceramide deciphering its protective effects on human skin by preventing moisture loss. It has been anticipated that ceramides, fatty acids, and cholesterol in combination with hydrocortisone (HC) can be an useful therapeutic agents against xerosis and atopic dermatitis. In addition, report also showed that topical emulsions containing ceramides possessed anti-inflammatory and skin beneficial properties. Hence, isolation of ceramide from natural source possessing anti-inflammatory and skin protective properties becomes vital.
The beneficial effects of oral intake of plant-derived ceramides for skin hydration and skin barrier reinforcement have been established in several studies involving animal models as well as human subjects. A randomized, double-blind placebo-controlled trial was conducted on women with dry skin to investigate the moisturizing effect of dietary supplement containing wheat extract enriched with ceramides and digalactosyldiglycerides (DGDG). According to the finding, there was a significant increase in skin hydration with improved associated clinical signs (itching, squamae, roughness, and redness). Ingestion of konjac ceramides has also shown positive effects in atopic dermatitis patients as well as healthy volunteers. Results showed improved skin symptoms and reduced skin allergic responses . The foregoing studies support the beneficial effects of oral intake of plant ceramides and their potential complementary and alternative therapeutic applications in the restoration and maintenance of skin barrier function. However, the findings from human study are still very limited, more detailed and comprehensive studies are still required to document the clinical efficacy of oral supplementation of ceramides. Thus, this study aims to evaluate the effects of rice ceramides consumption in improving skin health.
Objective
To determine the effects of rice ceramides consumption in improving skin health.
METHODOLOGY
Study Design
This will be an open-label, single arm, prospective interventional study that involves three-months period of rice ceramides (komercera) supplementation. Fifty subjects will be recruited via convenient sampling for this study.
Study Population
Fifty subjects are required to consume rice ceramides (komecera) supplements at the dosage of 40mg, one vegetarian capsule per day. Monthly follow-up for the duration of 3 months will be conducted to allow sufficient time for the changes to take place.
Good general healthy subjects who are free from any skin diseases, aged 20 to 45 and willing to comply with rice ceramides consumption plan will be recruited. Participant with underlying skin medical condition such as eczema, psoriasis, rosacea, atopic dermatitis, ichthyosis or vitiligo, undergoing medication plan, currently taking antimicrobial or antiviral medication, undergone major surgical procedures in the past six months, pregnant or lactating woman will be excluded from this study. All the study participants will be provided with a participant information sheet, briefly containing the research detail and a written informed consent will also be sought from each recruited participant.
Assessment will be conducted at baseline when they were first recruited, and also during their 3 times monthly follow ups. Participants will be remunerated with RM200 vouchers by the end of the study to compensate the time they spent in this research. Location of recruitment will be at public settings in Klang Valley.
Clinical Assessment
The efficacy of rice ceramides in improving the overall skin health will be assessed using the parameters below: -
- Total Wrinkle Score (TWS)
- Skin firmness and elasticity (Courage \& Khazaka Cutometer®, MPA580)
- Skin hydration (Courage \& Khazaka Corneometer®, CM825)
- Transepidermal Water Loss and Skin Barrier Function (Courage \& Khazaka Tewameter®, TM 300)
- Skin whitening (Courage \& Khazaka Mexameter®, MX18)
- Sebum Secretion (Courage \& Khazaka Sebumeter®, SM815)
- Skin pH (Courage \& Khazaka pH meter®, PH900)
The assessment mentioned above will be carried out using Multiprobe Adapter System (MPA), which is a non-invasive assessment.
Subjects Self-Perceived Assessment
Subject will also be required to do a self-perceived Visual Analogue Scale (VAS) to reflect their self-perceived changes.
Statistical Analysis
Demographic characteristics will be presented as categorical data, expressed in frequency and percentage. All outcomes will be analyzed as continuous dependent variables, presented as mean ± SD. The changes in clinical assessment from baseline visit to last follow-up visit will be analyzed using general linear model (GLM) for repeated measures model. Within-subjects factor will be defined as the sampling time point. Gender and age will be tested as between-subject effect. Homogeneity of the variance and covariance structure of the dependent variables will be assessed by Levene and Box M tests. Sphericity test of the residual covariance matrix will be assessed using Mauchly's sphericity test. Results will only be considered significant if P<0.05 with 95% of confidence interval. Statistical analysis will be performed using SPSS 26.0 (IBM Corp., New York, United States) for MacOS.
- Conditions
- Skin Condition
- Being tested
- Rice ceramide supplementation
- Keywords
- Rice ceramide, Supplementation, Skin health
- Medical subject headings
- Skin Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Rice ceramide supplementationDietary supplement
At the dosage of 40mg daily for 3 months
| Study group | Role | What they receive |
|---|---|---|
| Treatment arm | Experimental | To receive rice ceramide supplementation for 3 months Receives: Dietary Supplement: Rice ceramide supplementation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Wrinkle change
To be assessed using Total Wrinkle Score (TWS). TWS has a minimum value of 4 and maximum value of 20, with higher values indicating higher severity.
Measured: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)
Change in skin firmness and elasticity
To be assessed using Courage \& Khazaka Cutometer®, MPA580
Measured: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)
Change in skin hydration
To be assessed using Courage \& Khazaka Corneometer®, CM825
Measured: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)
Change in transepidermal water loss and skin barrier function
To be assessed using Tewameter® TM 300
Measured: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)
Change in skin whitening
To be assessed using Courage \& Khazaka Mexameter®, MX18
Measured: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)
Change in sebum secretion
To be assessed using Courage \& Khazaka Sebumeter®, SM815
Measured: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)
Change in skin pH
To be assessed using Courage \& Khazaka pH meter®, PH900
Measured: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)
Secondary outcomes (1)
Adverse events
Monitor for adverse response from participants
Measured: Follow-up visit month 3
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Nov 2021
- Study start1 Sep 2021
- Primary completion31 Jan 2022
- Study completion31 Mar 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (9)Papers the sponsor has linked to this study.
- Other trials for Skin ConditionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- This will be a single arm and open-labelled prospective study
- Masking
- None (open label)
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Nexus Wise Sdn Bhd
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- JScience Consultancy PLT
- Responsible party
- Principal investigator, Tan Chung Keat, Nexus Wise Sdn Bhd
- Investigators
- Chung Keat Tan, PhD, Principal investigator, UCSI University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05101421
- Sponsor's protocol ID
- NW-RC-001
- Status last verified
- Sep 2022
- First submitted
- 16 Oct 2021
- Last updated
- 28 Sep 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: It can be shared upon the completion of this study
Publications
Henderson AJ, Ollila CA, Kumar A, Borresen EC, Raina K, Agarwal R, Ryan EP. Chemopreventive properties of dietary rice bran: current status and future prospects. Adv Nutr. 2012 Sep 1;3(5):643-53. doi: 10.3945/an.112.002303.
PubMed 22983843Heule F. An oral approach to the treatment of photodamaged skin: a pilot study. J Int Med Res. 1992 Jun;20(3):273-8. doi: 10.1177/030006059202000309.
PubMed 1397672Kawano K, Umemura K. Oral intake of beet extract provides protection against skin barrier impairment in hairless mice. Phytother Res. 2013 May;27(5):775-83. doi: 10.1002/ptr.4792. Epub 2012 Sep 4.
PubMed 22949397Yeom M, Kim SH, Lee B, Han JJ, Chung GH, Choi HD, Lee H, Hahm DH. Oral administration of glucosylceramide ameliorates inflammatory dry-skin condition in chronic oxazolone-induced irritant contact dermatitis in the mouse ear. J Dermatol Sci. 2012 Aug;67(2):101-10. doi: 10.1016/j.jdermsci.2012.05.009. Epub 2012 Jun 7.
PubMed 22726258Asai S, Miyachi H. [Evaluation of skin-moisturizing effects of oral or percutaneous use of plant ceramides]. Rinsho Byori. 2007 Mar;55(3):209-15. Japanese.
PubMed 17441463Guillou S, Ghabri S, Jannot C, Gaillard E, Lamour I, Boisnic S. The moisturizing effect of a wheat extract food supplement on women's skin: a randomized, double-blind placebo-controlled trial. Int J Cosmet Sci. 2011 Apr;33(2):138-43. doi: 10.1111/j.1468-2494.2010.00600.x.
PubMed 20646083Imokawa G, Akasaki S, Hattori M, Yoshizuka N. Selective recovery of deranged water-holding properties by stratum corneum lipids. J Invest Dermatol. 1986 Dec;87(6):758-61. doi: 10.1111/1523-1747.ep12456950.
PubMed 3782858Kimata H. Improvement of atopic dermatitis and reduction of skin allergic responses by oral intake of konjac ceramide. Pediatr Dermatol. 2006 Jul-Aug;23(4):386-9. doi: 10.1111/j.1525-1470.2006.00268.x.
PubMed 16918640Miyanishi K, Shiono N, Shirai H, Dombo M, Kimata H. Reduction of transepidermal water loss by oral intake of glucosylceramides in patients with atopic eczema. Allergy. 2005 Nov;60(11):1454-5. doi: 10.1111/j.1398-9995.2005.00915.x. No abstract available.
PubMed 16197483
Study at a glance
From the registry record, last updated by the sponsor on 28 Sep 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effects of Rice Ceramide Supplementation in Improving Skin Health
- ClinicalTrials.gov ID
- NCT05101421
- Acronym / sponsor ID
- NW-RC-001
- Conditions
- Skin Condition
- Keywords
- Rice ceramide, Supplementation, Skin health
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Nexus Wise Sdn BhdIndustry (pharma, biotech, devices)
- Collaborators
- JScience Consultancy PLT
- Study start
- 1 Sep 2021 (actual)
- Primary completion
- 31 Jan 2022 (actual)
- Study completion
- 31 Mar 2022 (actual)
- First posted
- 1 Nov 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Ceramides have been added to newer cosmetic products to improve skin barrier function and exogenously replenish skin ceramides. Of the stratum corneum intercellular lipids, Ceramides are the most effective at restoring barrier function and increasing skin hydration. Different ceramides have been incorporated into cosmetic formulations, but understanding the differences between ceramides used in formulations, or even identifying ceramides in formulations can be complex. This is mostly because of an archaic nomenclature system that is fundamentally flawed based on current scientific evidence. In the recent past, due to the unique bioactive components of rice, it has been explored to a certain limit for its components. Further, much attention has been paid to the plant ceramide with its incorporation into cosmetics and food preparations owing to its safety in contrast to animal/synthetic origin. There are reports on plant ceramide deciphering its protective effects on human skin by preventing moisture loss. It has been anticipated that ceramides, fatty acids, and cholesterol in combination with hydrocortisone (HC) can be an useful therapeutic agents against xerosis and atopic dermatitis.
The beneficial effects of oral intake of plant-derived ceramides for skin hydration and skin barrier reinforcement have been established in several studies involving animal models as well as human subjects. Ingestion of konjac ceramides has also shown positive effects in atopic dermatitis patients as well as healthy volunteers. Results showed improved skin symptoms and reduced skin allergic responses. The foregoing studies support the beneficial effects of oral intake of plant ceramides and their potential complementary and alternative therapeutic applications in the restoration and maintenance of skin barrier function. However, the findings from human study are still very limited, more detailed and comprehensive studies are still required to document the clinical efficacy of oral supplementation of ceramides. Thus, this study aims to evaluate the effects of rice ceramides consumption in improving skin health.
Detailed description
EFFECTS OF RICE CERAMIDES IN IMPROVING SKIN HEALTH - STUDY PROTOCOL
INTRODUCTION
Background
Ceramides are important structural components of the epidermis, which plays a key role in maintaining homeostasis of the human body. Specifically, its outermost layer, known as the stratum corneum, forms a barrier between the external environment and the internal body. This barrier function serves multiple purposes including prevention of water loss and protection from foreign insult. The structure of the stratum corneum is often referred to as ''brick and mortar''. The ''bricks'' are terminally differentiated keratinocytes composed mostly of keratin filaments and filaggrin. The ''mortar'' is composed of intercellular lipids arranged into lamellar layers consisting of ceramides, free fatty acids, and cholesterol. Ceramides are the predominant lipid comprising approximately 50% of the intercellular lipid content by mass. Stratum corneum lipids are essential for maintaining skin barrier function and preventing transepidermal water loss (TEWL). Disruptions or damage to the stratum corneum can impair skin barrier function and result in TEWL.
Ceramides have been added to newer cosmetic products to improve skin barrier function and exogenously replenish skin ceramides. Of the stratum corneum intercellular lipids, Ceramides are the most effective at restoring barrier function and increasing skin hydration. Different ceramides have been incorporated into cosmetic formulations, but understanding the differences between ceramides used in formulations, or even identifying ceramides in formulations can be complex. This is mostly because of an archaic nomenclature system that is fundamentally flawed based on current scientific evidence. In the recent past, due to the unique bioactive components of rice, it has been explored to a certain limit for its components. Further, much attention has been paid to the plant ceramide with its incorporation into cosmetics and food preparations owing to its safety in contrast to animal/synthetic origin. There are reports on plant ceramide deciphering its protective effects on human skin by preventing moisture loss. It has been anticipated that ceramides, fatty acids, and cholesterol in combination with hydrocortisone (HC) can be an useful therapeutic agents against xerosis and atopic dermatitis. In addition, report also showed that topical emulsions containing ceramides possessed anti-inflammatory and skin beneficial properties. Hence, isolation of ceramide from natural source possessing anti-inflammatory and skin protective properties becomes vital.
The beneficial effects of oral intake of plant-derived ceramides for skin hydration and skin barrier reinforcement have been established in several studies involving animal models as well as human subjects. A randomized, double-blind placebo-controlled trial was conducted on women with dry skin to investigate the moisturizing effect of dietary supplement containing wheat extract enriched with ceramides and digalactosyldiglycerides (DGDG). According to the finding, there was a significant increase in skin hydration with improved associated clinical signs (itching, squamae, roughness, and redness). Ingestion of konjac ceramides has also shown positive effects in atopic dermatitis patients as well as healthy volunteers. Results showed improved skin symptoms and reduced skin allergic responses . The foregoing studies support the beneficial effects of oral intake of plant ceramides and their potential complementary and alternative therapeutic applications in the restoration and maintenance of skin barrier function. However, the findings from human study are still very limited, more detailed and comprehensive studies are still required to document the clinical efficacy of oral supplementation of ceramides. Thus, this study aims to evaluate the effects of rice ceramides consumption in improving skin health.
Objective
To determine the effects of rice ceramides consumption in improving skin health.
METHODOLOGY
Study Design
This will be an open-label, single arm, prospective interventional study that involves three-months period of rice ceramides (komercera) supplementation. Fifty subjects will be recruited via convenient sampling for this study.
Study Population
Fifty subjects are required to consume rice ceramides (komecera) supplements at the dosage of 40mg, one vegetarian capsule per day. Monthly follow-up for the duration of 3 months will be conducted to allow sufficient time for the changes to take place.
Good general healthy subjects who are free from any skin diseases, aged 20 to 45 and willing to comply with rice ceramides consumption plan will be recruited. Participant with underlying skin medical condition such as eczema, psoriasis, rosacea, atopic dermatitis, ichthyosis or vitiligo, undergoing medication plan, currently taking antimicrobial or antiviral medication, undergone major surgical procedures in the past six months, pregnant or lactating woman will be excluded from this study. All the study participants will be provided with a participant information sheet, briefly containing the research detail and a written informed consent will also be sought from each recruited participant.
Assessment will be conducted at baseline when they were first recruited, and also during their 3 times monthly follow ups. Participants will be remunerated with RM200 vouchers by the end of the study to compensate the time they spent in this research. Location of recruitment will be at public settings in Klang Valley.
Clinical Assessment
The efficacy of rice ceramides in improving the overall skin health will be assessed using the parameters below: -
- Total Wrinkle Score (TWS)
- Skin firmness and elasticity (Courage \& Khazaka Cutometer®, MPA580)
- Skin hydration (Courage \& Khazaka Corneometer®, CM825)
- Transepidermal Water Loss and Skin Barrier Function (Courage \& Khazaka Tewameter®, TM 300)
- Skin whitening (Courage \& Khazaka Mexameter®, MX18)
- Sebum Secretion (Courage \& Khazaka Sebumeter®, SM815)
- Skin pH (Courage \& Khazaka pH meter®, PH900)
The assessment mentioned above will be carried out using Multiprobe Adapter System (MPA), which is a non-invasive assessment.
Subjects Self-Perceived Assessment
Subject will also be required to do a self-perceived Visual Analogue Scale (VAS) to reflect their self-perceived changes.
Statistical Analysis
Demographic characteristics will be presented as categorical data, expressed in frequency and percentage. All outcomes will be analyzed as continuous dependent variables, presented as mean ± SD. The changes in clinical assessment from baseline visit to last follow-up visit will be analyzed using general linear model (GLM) for repeated measures model. Within-subjects factor will be defined as the sampling time point. Gender and age will be tested as between-subject effect. Homogeneity of the variance and covariance structure of the dependent variables will be assessed by Levene and Box M tests. Sphericity test of the residual covariance matrix will be assessed using Mauchly's sphericity test. Results will only be considered significant if P<0.05 with 95% of confidence interval. Statistical analysis will be performed using SPSS 26.0 (IBM Corp., New York, United States) for MacOS.
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- This will be a single arm and open-labelled prospective study
| Arm | Type | Receives |
|---|---|---|
| Treatment arm | Experimental | Dietary Supplement: Rice ceramide supplementationTo receive rice ceramide supplementation for 3 months |
Who may qualify
- Ages
- 20 to 45 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Good general health
- Free from any skin diseases
- Willing to comply with rice ceramide consumption plan
- Willing to give consent
Key exclusion criteria (3 listed)
- Undergoing medication plan for skin condition
- Undergone major surgical procedures in the past six months
- Pregnant or lactating woman
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Rice ceramide supplementationAt the dosage of 40mg daily for 3 months | Dietary supplement | Treatment arm |
Primary outcome
Wrinkle change
Time frame: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)
To be assessed using Total Wrinkle Score (TWS). TWS has a minimum value of 4 and maximum value of 20, with higher values indicating higher severity.
Change in skin firmness and elasticity
Time frame: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)
To be assessed using Courage \& Khazaka Cutometer®, MPA580
Change in skin hydration
Time frame: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)
To be assessed using Courage \& Khazaka Corneometer®, CM825
Change in transepidermal water loss and skin barrier function
Time frame: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)
To be assessed using Tewameter® TM 300
Change in skin whitening
Time frame: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)
To be assessed using Courage \& Khazaka Mexameter®, MX18
Change in sebum secretion
Time frame: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)
To be assessed using Courage \& Khazaka Sebumeter®, SM815
Change in skin pH
Time frame: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)
To be assessed using Courage \& Khazaka pH meter®, PH900
1 secondary outcome
Adverse events
Time frame: Follow-up visit month 3
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Sep 2022.
- Background: PubMed 22983843Henderson AJ, Ollila CA, Kumar A, Borresen EC, Raina K, Agarwal R, Ryan EP. Chemopreventive properties of dietary rice bran: current status and future prospects. Adv Nutr. 2012 Sep 1;3(5):643-53. doi: 10.3945/an.112.002303.
- Background: PubMed 1397672Heule F. An oral approach to the treatment of photodamaged skin: a pilot study. J Int Med Res. 1992 Jun;20(3):273-8. doi: 10.1177/030006059202000309.
- Background: PubMed 22949397Kawano K, Umemura K. Oral intake of beet extract provides protection against skin barrier impairment in hairless mice. Phytother Res. 2013 May;27(5):775-83. doi: 10.1002/ptr.4792. Epub 2012 Sep 4.
- Background: PubMed 22726258Yeom M, Kim SH, Lee B, Han JJ, Chung GH, Choi HD, Lee H, Hahm DH. Oral administration of glucosylceramide ameliorates inflammatory dry-skin condition in chronic oxazolone-induced irritant contact dermatitis in the mouse ear. J Dermatol Sci. 2012 Aug;67(2):101-10. doi: 10.1016/j.jdermsci.2012.05.009. Epub 2012 Jun 7.
- Results publication: PubMed 17441463Asai S, Miyachi H. [Evaluation of skin-moisturizing effects of oral or percutaneous use of plant ceramides]. Rinsho Byori. 2007 Mar;55(3):209-15. Japanese.
- Results publication: PubMed 20646083Guillou S, Ghabri S, Jannot C, Gaillard E, Lamour I, Boisnic S. The moisturizing effect of a wheat extract food supplement on women's skin: a randomized, double-blind placebo-controlled trial. Int J Cosmet Sci. 2011 Apr;33(2):138-43. doi: 10.1111/j.1468-2494.2010.00600.x.
- Results publication: PubMed 3782858Imokawa G, Akasaki S, Hattori M, Yoshizuka N. Selective recovery of deranged water-holding properties by stratum corneum lipids. J Invest Dermatol. 1986 Dec;87(6):758-61. doi: 10.1111/1523-1747.ep12456950.
- Results publication: PubMed 16918640Kimata H. Improvement of atopic dermatitis and reduction of skin allergic responses by oral intake of konjac ceramide. Pediatr Dermatol. 2006 Jul-Aug;23(4):386-9. doi: 10.1111/j.1525-1470.2006.00268.x.
- Results publication: PubMed 16197483Miyanishi K, Shiono N, Shirai H, Dombo M, Kimata H. Reduction of transepidermal water loss by oral intake of glucosylceramides in patients with atopic eczema. Allergy. 2005 Nov;60(11):1454-5. doi: 10.1111/j.1398-9995.2005.00915.x. No abstract available.
- Individual participant dataSharing planned: Yes. It can be shared upon the completion of this study
Related trials for Skin Condition
RecruitingObservational study
Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
Dermatologic Conditions, Healthy Volunteers
RecruitingPhase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Areata Alopecia, Alopecia
RecruitingPhase 3
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
Actinic Keratosis
RecruitingPhase 3
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
Actinic Keratosis
Active, not recruiting
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
Skin Laxity, Wrinkle
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Chung Keat Tan, PhD principal investigator
UCSI University
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Rice ceramide supplementation in people with Skin Condition, run by Nexus Wise Sdn Bhd at 2 sites in Malaysia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Malaysia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Wrinkle change (time frame: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05101421, which also lists 9 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2022; AzTrials last refreshed its copy on 7 Nov 2026.